U.S. Markets open in 4 hrs 32 mins

ImmuPharma plc (IMM.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
47.00-2.00 (-4.08%)
As of 8:49AM BST. Market open.
Full screen
Previous Close49.00
Open49.25
Bid47.00 x 2000000
Ask48.75 x 850000
Day's Range47.00 - 49.25
52 Week Range31.44 - 70.32
Volume15,782
Avg. Volume183,440
Market Cap62.29M
BetaN/A
PE Ratio (TTM)-10.44
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Is ImmuPharma plc (AIM:IMM) Undervalued?
    Simply Wall St.14 days ago

    Is ImmuPharma plc (AIM:IMM) Undervalued?

    ImmuPharma plc (AIM:IMM), a pharmaceuticals, biotechnology and life sciences company based in United Kingdom, saw significant share price volatility over the past couple of months on the AIM, rising toRead More...

  • Reuters8 months ago

    Peter Thiel's New Zealand citizenship stokes political debate

    New Zealand's ruling centre-right National Party is heading into an election campaign plagued by questions over a decision to grant citizenship to Peter Thiel, a billionaire tech tycoon and adviser to U.S. President Donald Trump. Thiel was granted citizenship despite not meeting the normal requirement to live in the country for 75 percent of the time over five years, a fact that would normally disqualify an application. Centre-left Labour opposition member of Parliament Iain Lees-Galloway said in a statement the granting of citizenship raised "serious questions as to why a New Zealand passport needed to be granted to a wealthy foreign businessman who does not live here".

  • We're sorry this is all we were able to find about this topic.